Market Challenges: High cost of coronary artery bypass grafting procedures

The high cost of coronary artery bypass grafting (CABG) procedures can hamper the growth of global Coronary Artery Bypass Grafting Market. CABG is a major cardiac surgery that requires considerable hospital stay and has high costs associated with operation theater charges, equipment, postoperative care, medicines and extended stay in the ICU. According to the data published by the Centers for Disease Control and Prevention (CDC) in 2022, the average total hospital costs for CABG surgery in the U.S. range from US$ 80,000 to over US$ 150,000, depending on the complications involved and the facilities where the surgery is performed. These elevated costs pose a serious financial burden on patients and make CABG mostly unaffordable for the common masses, especially those living in developing nations with low per capita incomes. For many people, cardiac conditions are managed through alternate treatments and drug therapies despite being less effective compared to revascularization through CABG. According to a study published in 2021 by World Health Organization (WHO), around 57% of cardiovascular patients in low and lower-middle income countries opt out of CABG due to financial constraints compared to only 17% patients in high income countries. The costs involved also discourage private and public health insurers from including CABG in their insurance coverage in many emerging economies.

Market Opportunities: Development of innovative disposable and integrated device technologies

The development of innovative disposable and integrated device technologies can offer major opportunity for growth of global coronary artery bypass grafting market. Coronary artery bypass grafting or CABG is a widely performed procedure to treat coronary artery disease, one of the leading causes of mortality worldwide. While traditional CABG has been effective, new disposable and integrated device technologies have the potential to significantly improve outcomes and increase access to care. Some of the innovative technologies being developed could make the CABG procedure less invasive and reduce complications. For example, devices that integrate tissue harvesting, preparation and placement into a single-use cartridge or cassette. Such integrated devices streamline the workflow for surgeons and reduce the risk of infections from reuse of instruments. Similarly, fully disposable systems for tasks like vessel harvesting and graft optimization eliminate the need for cleaning and sterilization of equipment between procedures. This not only improves safety but allows for better inventory management and cost control for healthcare facilities. Fully disposable or rapidly deployable device suites could also enable the conduct of CABG procedures in ambulatory surgical centers or even in field hospitals. As per estimates by the World Bank, non-communicable diseases was projected to cost low- and middle-income countries US$ 7 trillion in economic losses from 2011 to 2025. Innovative technologies that optimize the CABG procedure and expand access to cardiac care in more points of service have potential to significantly reduce this growing economic burden of cardiovascular diseases in developing nations.